Ontology highlight
ABSTRACT: Objective
The mechanisms that determine the efficacy or inefficacy of MTX in JIA are ill-defined. The objective of this study was to identify a gene expression transcriptional signature associated with poor response to MTX in patients with JIA.Methods
RNA sequencing was used to measure gene expression in peripheral blood mononuclear cells collected from 47 patients with JIA prior to MTX treatment and 14 age-matched controls. Differentially expressed baseline genes between responders and non-responders were evaluated. Biological differences between all JIA patients and controls were explored by constructing a signature of differentially expressed genes. Unsupervised clustering and pathway analysis was performed.Results
A signature of 99 differentially expressed genes (Bonferroni-corrected P < 0.05) capturing the biological differences between all JIA patients and controls was identified. Unsupervised clustering of samples based on this list of 99 genes produced subgroups enriched for MTX response status. Comparing this gene signature with reference signatures from sorted cell populations revealed high concordance between the expression signatures of monocytes and of MTX non-responders. CXCL8 (IL-8) was the most significantly differentially expressed gene transcript comparing all JIA patients with controls (Bonferroni-corrected P = 4.12 × 10-10).Conclusion
Variability in clinical response to MTX in JIA patients is associated with differences in gene transcripts modulated in monocytes. These gene expression profiles may provide a basis for biomarkers predictive of treatment response.
SUBMITTER: Moncrieffe H
PROVIDER: S-EPMC5850489 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature
Moncrieffe Halima H Bennett Mark F MF Tsoras Monica M Luyrink Lorie K LK Johnson Anne L AL Xu Huan H Dare Jason J Becker Mara L ML Prahalad Sampath S Rosenkranz Margalit M O'Neil Kathleen M KM Nigrovic Peter A PA Griffin Thomas A TA Lovell Daniel J DJ Grom Alexei A AA Medvedovic Mario M Thompson Susan D SD
Rheumatology (Oxford, England) 20170901 9
<h4>Objective</h4>The mechanisms that determine the efficacy or inefficacy of MTX in JIA are ill-defined. The objective of this study was to identify a gene expression transcriptional signature associated with poor response to MTX in patients with JIA.<h4>Methods</h4>RNA sequencing was used to measure gene expression in peripheral blood mononuclear cells collected from 47 patients with JIA prior to MTX treatment and 14 age-matched controls. Differentially expressed baseline genes between respond ...[more]